Johns Hopkins Kimmel Cancer Center investigators report they have uncovered a new mechanism by which invasive breast cancer cells evade the immune system to metastasize, or spread, to other areas of the body. They propose that therapies targeting this process could be developed to halt or prevent metastasis and reduce breast cancer deaths. Natural killer (NK) […]
Elizabeth Jaffee
Cancer Matters with Dr. Bill Nelson – AACR President Dr. Elizabeth Jaffee
Posted by | podcastIn our next podcast, Dr Bill Nelson speaks with Kimmel Cancer Center Deputy Director, Dr Elizabeth Jaffee, to review her year as President of the American Association for Cancer Research and to assess the progress being made in the use of immune therapy to treat pancreatic cancer. In this preview, Dr Jaffee looks ahead to […]
Jaffee looks to the future of checkpoint immunotherapy for cancer treatment
Posted by | Issues & Perspectives, precision medicine, Prevention/Screening, treatmentCombinations strategies involving checkpoint immunotherapies were approved as first-line options in two cancer types and showed promise in clinical trials for several hard-to-treat cancers. Important advances were also made with respect to immune-related biomarkers, cellular immunotherapies, and personalized vaccines. Elizabeth Jaffee, M.D., deputy director of the Johns Hopkins Kimmel Cancer Center, is focusing her research […]
Cancer Matters with Dr. Bill Nelson – New AACR President Dr. Elizabeth Jaffee
Posted by | podcastDr Bill Nelson, the Director of the Kimmel Cancer Center at Johns Hopkins, begins a new podcast series focused on cancer treatment and research. In episode one, Dr Nelson speaks with Dr Elizabeth Jaffee, the Kimmel Cancer Center’s Deputy Director and the Associate Director of the Bloomberg~Kimmel Institute for Cancer Immunotherapy, from the annual meeting […]